in vitro News and Research

RSS

Novel bioreactor to repair vocal chords

Damaged or diseased vocal cords can forever change and even silence the voices we love, from a family member's to a famous personality's.

31 Jul 2007

New approach to rapid identification and development of malaria vaccines

Malaria is the world's most frequent parasitic disease, affecting more than 100 countries in the tropical zones, mostly in Africa, and 40% of the world population, with more than a million deaths per year.

25 Jul 2007

Antibody targets nanotubes to tumors

Researchers at Memorial Sloan-Kettering Cancer Center have created biocompatible single-walled carbon nanotubes that can target lymphomas and deliver both imaging and therapeutic molecules to these tumors.

23 Jul 2007

Sperm freezing for young male cancer patients

A recent study at Hamilton Health Sciences proves that sperm freezing and banking is an effective way to preserve fertility in adolescents and young adult (AYA) males with cancer.

23 Jul 2007

Koronis Pharmaceuticals issued U.S. patent for KP-1461 therapeutic in development for treatment of HIV

Koronis Pharmaceuticals, Inc. has announced the issuance of U.S. Patent No. 7,244,732 that discloses the composition of KP-1461 -- the Company's lead antiviral therapeutic currently in a Phase 2 trial for the treatment of human immunodeficiency virus (HIV) infection.

23 Jul 2007

Study reveals surge in male-factor infertility technique

A national study reveals that the use of intracytoplasmic sperm injection or ICSI -- an assisted reproductive technology used to treat male-factor infertility -- has increased dramatically in the United States since 1995, while the proportion of patients receiving treatment for male-factor infertility has remained stable.

18 Jul 2007

FDA approves gene test to detect spread of breast cancer into lymph nodes

Veridex, LLC, a Johnson & Johnson company, has announced U.S. Food and Drug Administration (FDA) approval of the first intra-operative and gene-based test to detect the spread of breast cancer into the lymph nodes.

17 Jul 2007

Startling discovery on the development of human embryonic stem cells

In this week's Nature, researchers of the McMaster Cancer and Stem Cell Research Institute show that human embryonic stem (ES) cells can actually produce distinctive niche cells, which then release stem-cell nourishing proteins to help keep their parents ticking over.

12 Jul 2007

Hydroxychloroquine may reduce risk of diabetes in patients with rheumatoid arthritis

Preliminary research suggests that use of the anti-malarial drug hydroxychloroquine may help reduce the risk of the development of diabetes in patients with rheumatoid arthritis, according to a study in the July 11 issue of JAMA .

11 Jul 2007

Bio-adhesive vaginal foam

Foamix Ltd. has announced that the Company has been selected to present at the 34th Annual Meeting of the Controlled Release Society.

10 Jul 2007

Chemical in brain acts like a fuel gauge

The concept that a drop in blood sugar triggers a craving for food is best understood just before lunchtime. But exactly how the process unfolds has proven difficult to explain, even on a full stomach.

9 Jul 2007

Discovery of two effective antibodies for SARS

An international team of investigators has identified the first human antibodies that can neutralize different strains of the virus responsible for outbreaks of severe acute respiratory syndrome (SARS).

4 Jul 2007

Genetic embryo screening found to be a costly mistake for many women

According to a new study older women whose embryos were screened for defects before being implanted in the womb lessened their chance of a successful pregnancy.

4 Jul 2007

Baby girl created using new lab technique

Canadian researchers have scored a world first by creating a baby from an egg which matured in the laboratory, was frozen, thawed and then fertilised.

3 Jul 2007

Roche makes offer to acquire Ventana Medical Systems

Roche will make a tender offer to acquire all outstanding shares of common stock of Ventana Medical Systems for $75.00 per share in cash, or an aggregate of approximately $3 billion on a fully diluted basis.

From Roche Sequencing and Life Science 26 Jun 2007

Alogliptin for type 2 diabetes shows promise in early trial

Alogliptin, a highly selective dipeptidyl peptidase-IV (DPP-4) inhibitor under investigation for the treatment of type 2 diabetes, demonstrated efficacy in reducing glucose levels throughout the day, in an early phase clinical study.

26 Jun 2007

SSRIs associated with lower bone density in older men and women

The class of antidepressant medications known as selective serotonin reuptake inhibitors may be associated with an increased rate of bone loss in older men and women, according to two articles in the June 25 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

26 Jun 2007